info@biomedres.us   +1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Research ArticleOpen Access

A Comparative Analysis of Medium-Distance Visual Performance in Patients Implanted with Comfort and Vario Intraocular Lenses Volume 63- Issue 1

Boryana Irinkova* and Iva Petkova

  • SHATED “Zora”, Petar Protich str.4, Bulgaria

Received: August 21, 2025; Published: September 02, 2025

*Corresponding author: Boryana Irinkova, SHATED “Zora”, Petar Protich str.4, 1750, Sofia, Bulgaria

DOI: 10.26717/BJSTR.2025.63.009842

Abstract PDF

ABSTRACT

This study aims to evaluate and compare medium-distance visual outcomes in patients implanted with Comfort and Vario IOLs. A total of 136 eyes were included: 56 eyes with Comfort IOLs, 80 eyes with Vario IOLs. Medium- distance visual acuity at 70 cm was tested for bought IOLs after surgery at different timepoints. Preoperative evaluation of medium-distance vision was omitted due to cataract-induced inaccuracies. Comfort IOLs, utilizing advanced aspheric optics, and Vario IOLs, employing diffractive and refractive designs, were investigated to determine their efficacy in enhancing intermediate visual acuity, a key determinant of daily visual function and patient satisfaction after operation.

Introduction

Cataract surgery has advanced beyond simple vision restoration to become a procedure that enhances patients’ quality of life through improved visual acuity at various distances [1]. Conventional monofocal intraocular lenses (IOLs) provide excellent distance vision but often necessitate the use of spectacles for intermediate and near tasks [2]. This limitation has led to the development of enhanced monofocal and extended depth of focus (EDoF) IOLs, such as Comfort and Vario lenses, which aim to extend the range of functional vision without compromising visual quality through dysphotopsias [2,3]. Comfort IOLs use refined aspheric optics to increase depth of focus, delivering superior visual acuity at intermediate distances with minimal side effects like glare or halos [4]. These enhanced monofocal lenses are particularly suited for tasks such as computer work, offering a broader focal range while preserving contrast sensitivity [5]. VarioIOLs employ wavefront-shaping or diffractive technologies to create an extended zone of focus [6]. These lenses function by creating a continuous elongated focal zone, thereby providing clearer vision across a broader range of distances, particularly benefiting intermediate vision. This optical design aims to reduce chromatic and spherical aberrations, providing clearer vision across a range of distances, particularly for intermediate tasks [7,8]. Despite the growing use of these lenses, few studies have directly compared their performance at medium distances (around 70 cm), which are critical for modern lifestyle activities. This study aims to compare medium-distance visual outcomes between patients implanted with Comfort and Vario IOLs, evaluating visual acuity, patient-reported visual quality, and satisfaction rates.

Materials and Methods

Study Design

This prospective, comparative study was conducted in accordance with the Declaration of Helsinki and approved by the institutional review board. Patients undergoing routine cataract surgery were devided into two groups depending on the type of IOL chosen: Comfort IOLs (56 eyes) and Vario IOLs (80 eyes). Preoperative medium- distance vision was not assessed, as the presence of cataracts would compromise measurement accuracy and reliability.

Inclusion and Exclusion Criteria

Patients aged between 55 and 80 years, diagnosed with cataract, and without visually significant ocular comorbidities such as glaucoma, macular degeneration, or diabetic retinopathy were included. Patients with previous ocular surgeries, irregular corneal astigmatism exceeding 1.0 D, or other ocular pathologies impacting visual function were excluded.

Surgical Procedure

All surgeries were performed by 2 surgeons using standard phacoemulsification techniques. IOL power calculation was conducted using optical biometry and Zeiss IOL Master 700 and SRK-T, Hollady, Barrett Universal II formula to optimize refractive outcomes, targeting emmetropia.

Postoperative Assessment

Patients underwent comprehensive ophthalmic evaluations before the operation, at week 2, month three, and six months postoperatively. Medium-distance visual acuity was assessed at 70 cm using specialized ETDRS charts under standardized illumination conditions. The 70 cm test distance was selected to approximate typical computer workstation viewing distance, thereby measuring functional intermediate vision relevant to daily tasks such as monitor use and document reading.

Statistical Analysis

Data were analyzed using descriptive statistics for demographic characteristics and inferential statistics (SPSS-19, Fisher test and Sparman test) to compare visual outcomes between groups. Statistical significance was defined as a p-value less than 0.05.

Results

Comfort IOL: Medium-distance (70 cm) Best-Corrected Visual Acuity Over Time

(Graph 1) Among eyes implanted with the Comfort IOL (n=56), the distribution of decimal visual acuity (VA) at 70 cm improved progressively from 2 weeks to 6 months postoperatively is shown in (Tables 1 & 1A) and the accompanying graph. Improvement is achieved from week 2 to month 6, where over 80% of the subject achieve vision above 0,7. Fisher exact tests comparing timepoints and achieved results demonstrated a significant shift toward better medium-distance VA between 2 weeks and 6 months as well:

• >0.7: 58.9% → 82.1%; p = 0.0129 (2w vs 6m).
• 0.4–0.7: 33.9% → 16.1%; p = 0.0495 (2w vs 6m).
• ≤0.4: 7.1% → 1.8%; p = 0.3601 (2w vs 6m).

Graph 1

biomedres-openaccess-journal-bjstr

Table 1: Distribution of best-corrected medium-distance (70 cm) visual acuity after Comfort IOL implantation (n = 56). Values are n (%).

biomedres-openaccess-journal-bjstr

Table 1A: Fisher’s exact p values for category proportions (Comfort).

biomedres-openaccess-journal-bjstr

Note: Bold indicates p < 0.05.

No statistically significant changes were observed between 2 weeks and 3 months (>0.7: p = 0.2340; 0.4–0.7: p = 0.5376; ≤0.4: p = 0.3601) or between 3 and 6 months (>0.7: p = 0.2631; 0.4–0.7: p = 0.2496; ≤0.4: p = 1.0000) respectively.

Clinical Interpretation

Most Comfort-implanted eyes achieved functional medium-distance acuity (>0.7 decimal, approximately ~20/30 Snellen) as early as 2 weeks, with additional, statistically significant gains by 6 months. This improvement plateaued between 3 and 6 months, suggesting refractive stability and neural adaptation [9,10]. The pattern is showing the expected postoperative refractive stabilization and continuing neuroadaptation.

Vario IOL: Medium-distance (70 cm) Best-Corrected Visual Acuity Over Time

(Graph 2) Among eyes implanted with the Vario IOL (n = 80), the distribution of medium-distance VA at 70 cm showed progressive improvement from 2 weeks to 6 months as shown in tale 2 and the graphic respective graphic. The statistical analysis shows improvement by month 6, where over 65% of eyes have VA over 0,7 (Tables 2 & 2A).

Graph 2

biomedres-openaccess-journal-bjstr

Table 2: Distribution of best-corrected medium-distance (70 cm) visual acuity after Vario IOL implantation (n = 80). Values are n (%).

biomedres-openaccess-journal-bjstr

Table 2A: Fisher’s exact p values for category proportions (Vario).

biomedres-openaccess-journal-bjstr

Note: Bold indicates p < 0.05.

The Fisher exact tests demonstrated a significant shift toward better medium-distance VA between 2 weeks and 6 months:

o >0.7: 45.0% → 65.0%; p = 0.0171 (2w vs 6m).
o ≤0.4: 11.3% → 1.3%; p = 0.0222 (2w vs 6m).
o 0.4–0.7: 43.8% → 33.8%; p = 0.2560 (2w vs 6m).

No statistically significant changes were observed between 2 weeks and 3 months (≤0.4: p = 0.4013; 0.4–0.7: p = 0.5197; >0.7: p = 0.2059) or between 3 and 6 months (≤0.4: p = 0.2119; 0.4–0.7: p = 0.7413; >0.7: p = 0.3316).

Clinical Interpretation

Nearly half of Vario-implanted eyes achieved functional medium- distance acuity (>0.7 decimal, ≈20/30 Snellen) as early as 2 weeks, with further improvement to 65% by 6 months. The statistically significant results from 2 weeks to 6 months and the plateau between 3 and 6 months are consistent with postoperative refractive stabilization and continuous neuroadaptation for EDoF optics, very much like the results observed in the Comfort group.

Between-group comparison: Comfort vs Vario at 70 cm (proportion with VA > 0.7)

(Graph 3) Using Fisher’s exact test to compare the proportion of eyes achieving VA > 0.7 at 70 cm between the Comfort and Vario cohorts at matched timepoints showed a significant difference only at 6 months (Tables 3 & 4):

• 2 weeks: Comfort 58.9% vs Vario 45.0%; p = 0.1542 (ns).
• 3 months: Comfort 71.4% vs Vario 56.3%; p = 0.1053 (ns).
• 6 months: Comfort 82.1% vs Vario 65.0%; p = 0.0457.

Graph 3

biomedres-openaccess-journal-bjstr

Table 3: Fisher’s exact p values for between group comparison (Comfort vs Vario) of the proportion with best-corrected medium distance VA > 0.7 (decimal).

biomedres-openaccess-journal-bjstr

Table 4: Comfort vs Vario at 70 cm dynamic.

biomedres-openaccess-journal-bjstr

Clinical Interpretation

While both IOLs show improvement in medium distance function, by 6 months the Comfort lens demonstrated a higher probability of achieving VA > 0.7 at 70 cm relative to the Vario EDoF design. Early postoperative results (2 weeks, 3 months) show the same direction but did not reach statistical significance. This suggests that, in this population, the Comfort may provide an advantage for medium distance vision by 6 months, though the clinical significance should be measured against other performance points (depth of focus, dysphotopsia), to be tested and analyzed in future studies.

Discussion

The aim of this study was to explore how Comfort and Vario IOLs perform in real-world, medium-distance vision tasks-things like reading on a screen or viewing objects at arm’s length, which are essential to daily life. While previous research has shown lenses like the Comfort IOL often provide better intermediate vision than standard monofocal lenses-without significant issues like glare or halos-direct comparisons with the Vario, are still relatively scarce. EDoF lenses were specifically designed to address some of the limitations in both monofocal and multifocal IOLs, offering a smoother visual experience across a wider range of distances while minimizing light-related disturbances. Studies on Vario lenses have reported promising results, especially for intermediate tasks, with outcomes often matching or even surpassing those of multifocal lenses when it comes to patient satisfaction. By directly comparing these two technologies, this study provides valuable insight that can help eye care professionals choose the most suitable lens for each patient. Finding the right balance between quality vision, depth of focus, and overall satisfaction is more important than ever, especially as intermediate vision plays an important role in maintaining independence and quality of life.

The results affirm that both IOLs enhance medium-distance vision after cataract surgery. However, Comfort IOLs showed a statistically significant advantage in reaching higher VA at a fixed 70 cm distance. This aligns with prior findings suggesting enhanced monofocal lenses can deliver excellent intermediate vision without the dysphotopsias often associated with multifocal designs [4,5,9]. Vario IOLs also performed well, particularly in their ability to offer a broader continuous focus range, a hallmark of EDoF lenses [7,8,10-11]. While their peak intermediate acuity was slightly lower, their performance may be better across varying intermediate distances, which this study did not measure.

Conclusion

Both Comfort and Vario IOLs significantly improved medium-distance vision after cataract surgery. By 6 months post-op, 82.1% of Comfort IOL recipients achieved functional VA (>0.7) compared to 65.0% with Vario lenses. While Comfort lenses provided slightly better performance at a specific working distance (70 cm), Vario lenses remain valuable for patients seeking a broader range of spectacle-free intermediate vision. Lens selection should be based on individual visual priorities-those focused on specific workstation clarity may benefit more from Comfort IOLs, while those preferring a continuous range may opt for Vario IOLs.

Limitations

This analysis focuses on categorical acuity and the parallel assessments of contrast sensitivity and dysphotopsia are in the process of being analyzed. Future work will incorporate this analysis to broaden and enhance the study.

References

  1. Gundersen KG, Potvin R (2017) Trifocal intraocular lenses: a comparison of the visual performance and quality of vision provided by two different lens designs. Clinical Ophthalmology 11: 1081-1087.
  2. Mencucci R, Cennamo M, Favuzza E (2020) Visual outcome, optical quality, and patient satisfaction with a new monofocal IOL enhanced for intermediate vision. Journal of Cataract & Refractive Surgery 46(3): 381-387.
  3. Tanabe H, Shojo T, Akada M (2022) Comparative visual performance of diffractive bifocal and asymmetric refractive IOLs. Scientific Reports 12: 20898.
  4. Pedrotti E, Mastropasqua R, Bonetto J, Christian Demasi, Francesco Aiello, et al. (2018) Quality of vision and satisfaction after low addition multifocal IOLs. International Ophthalmology 38: 985-992.
  5. Darian Smith E, Versace P (2020) Visual performance and stability of a capsulorhexis-fixated EDoF IOL. Journal of Cataract & Refractive Surgery 46(2): 198-203.
  6. Kohnen T, Böhm M, Hemkeppler E (2019) Visual performance of extended depth of focus IOLs for treatment selection. Eye 33: 1230-1237.
  7. Sandoval HP, Potvin R, Solomon KD (2020) Satisfaction with combined EDoF and multifocal IOLs. Clinical Ophthalmology 14: 1379-1387.
  8. Wang J, Luo J, Yang W, Ruoxin Ren, Yi Xie, et al. (2024) Efficacy and comfort after implantation of extended depth of focus and multifocal IOLs. BMC Ophthalmology 24(1).
  9. Ruiz Mesa R, Abengózar Vela A, García García J (2018) Visual outcomes of trifocal vs Extended Depth of Focus IOLs. European Journal of Ophthalmology 28(2): 182-188.
  10. Gillmann K, Mermoud A (2019) Quality of life with central EDoF lenses. Klinische Monatsblätter für Augenheilkunde 236(8): 936-943.
  11. Can İ, Bayhan HA (2024) Clinical Outcomes of Enhanced Monofocal (Mono-EDOF) Intraocular Lenses with the Mini-Monovision Technique versus Trifocal Intraocular Lenses: A Comparative Study. Turk J Ophthalmol 54: 190-197